1. Home
  2. COMP vs CYTK Comparison

COMP vs CYTK Comparison

Compare COMP & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COMP
  • CYTK
  • Stock Information
  • Founded
  • COMP 2012
  • CYTK 1997
  • Country
  • COMP United States
  • CYTK United States
  • Employees
  • COMP N/A
  • CYTK N/A
  • Industry
  • COMP EDP Services
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • COMP Technology
  • CYTK Health Care
  • Exchange
  • COMP Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • COMP 4.9B
  • CYTK 4.6B
  • IPO Year
  • COMP 2021
  • CYTK 2004
  • Fundamental
  • Price
  • COMP $9.46
  • CYTK $47.56
  • Analyst Decision
  • COMP Buy
  • CYTK Buy
  • Analyst Count
  • COMP 8
  • CYTK 15
  • Target Price
  • COMP $9.75
  • CYTK $75.57
  • AVG Volume (30 Days)
  • COMP 7.2M
  • CYTK 2.9M
  • Earning Date
  • COMP 10-29-2025
  • CYTK 11-05-2025
  • Dividend Yield
  • COMP N/A
  • CYTK N/A
  • EPS Growth
  • COMP N/A
  • CYTK N/A
  • EPS
  • COMP N/A
  • CYTK N/A
  • Revenue
  • COMP $6,290,200,000.00
  • CYTK $85,738,000.00
  • Revenue This Year
  • COMP $24.34
  • CYTK $330.96
  • Revenue Next Year
  • COMP $12.93
  • CYTK $73.41
  • P/E Ratio
  • COMP N/A
  • CYTK N/A
  • Revenue Growth
  • COMP 21.23
  • CYTK 2635.74
  • 52 Week Low
  • COMP $5.10
  • CYTK $29.31
  • 52 Week High
  • COMP $10.25
  • CYTK $59.39
  • Technical
  • Relative Strength Index (RSI)
  • COMP 61.66
  • CYTK 56.53
  • Support Level
  • COMP $9.15
  • CYTK $49.22
  • Resistance Level
  • COMP $9.60
  • CYTK $53.58
  • Average True Range (ATR)
  • COMP 0.36
  • CYTK 2.73
  • MACD
  • COMP -0.06
  • CYTK -0.07
  • Stochastic Oscillator
  • COMP 59.84
  • CYTK 64.95

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: